Atlas Trials

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Clinical trial NCT00517517 · COMPLETED

Trial details

NCT number
NCT00517517
Sponsor
Alachua Government Services, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2007-07-01
Primary completion
2007-09-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.